Results 171 to 180 of about 1,360,875 (361)
Inhibition of EYA family tyrosine phosphatase activity reveals a therapeutic vulnerability and enhances Menin and DOT1L inhibitor efficacy in KMT2A-rearranged leukemia. [PDF]
Badmus L +4 more
europepmc +1 more source
FOLIC ACID ANTAGONISTS IN THE TREATMENT OF ACUTE AND SUBACUTE LEUKEMIA [PDF]
William Dameshek +2 more
openalex +1 more source
This study investigates the deacetylation of ACLY at K978 acts as a novel risk in colorectal cancer chemoresistance. The deacetylation of K978 induces ACLY relocation to the nucleus and promotes its binding to RBM15, a m6A methylation modification “writer”.
Jun Wen +8 more
wiley +1 more source
The crosstalk between MiRNAs and autophagy in leukemia: mechanisms and therapeutic insights. [PDF]
Faghiri Beyrami A +4 more
europepmc +1 more source
This study uncovers a novel mechanism and therapeutic targets in obstetric antiphospholipid syndrome (OAPS). Antiphospholipid antibody/ß2‐glycoprotein I complex boosts CCL2 and TNF‐α expression in decidual macrophages via TLR4‐NF‐κB. CCL2 accumulates on endothelial surfaces via ACKR1, recruiting monocyte‐derived CCR2+ macrophages, driving inflammation,
Rui Gao +13 more
wiley +1 more source
B/T Mixed Phenotype Acute Leukaemia Harbouring <i>NUP98::BPTF</i> Fusion. [PDF]
Nguyen VT +7 more
europepmc +1 more source
Trends of Mortality from Leukemia in the United States, 1921-55 [PDF]
Alexander G. Gilliam, William Walter
openalex +1 more source

